• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 4. An autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapy?
  Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

Exploring (1R,4R)-2-Azabicyclo[2.2.1]heptan-5-one Hydrochloride (CAS 1228600-28-9): Properties, Applications, and Market Insights

The compound (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride (CAS 1228600-28-9) is a chiral bicyclic amine derivative that has garnered significant attention in pharmaceutical and chemical research. This molecule features a unique azabicyclo[2.2.1]heptane scaffold, which is increasingly recognized for its potential in drug discovery and development. The hydrochloride salt form enhances its stability and solubility, making it a valuable intermediate in synthetic chemistry.

One of the key structural features of (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride is its rigid bicyclic framework. This conformation restricts molecular flexibility, which can be advantageous in designing compounds with high binding affinity to biological targets. Researchers are particularly interested in how this azabicyclic structure influences pharmacokinetic properties and receptor interactions. The compound's stereochemistry at the 1 and 4 positions also plays a crucial role in its biological activity and synthetic applications.

In pharmaceutical applications, (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride serves as a versatile building block for the synthesis of various therapeutic agents. Its structural motif appears in several drug candidates targeting neurological disorders, with researchers exploring its potential in developing novel treatments for conditions like Parkinson's disease and depression. The pharmaceutical industry values such chiral building blocks for their ability to impart desired stereochemical properties to final drug molecules.

The synthesis of (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride typically involves asymmetric catalytic methods to control the stereochemistry at the bridgehead positions. Recent advancements in organocatalysis and transition metal catalysis have improved the efficiency of producing this compound with high enantiomeric purity. These synthetic approaches are particularly relevant given the growing demand for stereochemically pure pharmaceutical intermediates in drug development pipelines.

From a market perspective, the demand for specialized azabicyclic compounds like (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride continues to rise. Pharmaceutical companies and contract research organizations are actively seeking high-quality chiral intermediates to support their drug discovery programs. The compound's CAS number 1228600-28-9 has become an important identifier in chemical databases and procurement systems, reflecting its growing commercial significance.

Analytical characterization of (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride typically involves techniques such as chiral HPLC, NMR spectroscopy, and mass spectrometry. These methods are essential for verifying the compound's identity, purity, and stereochemical integrity. Quality control measures are particularly stringent for such intermediates, as even minor impurities can significantly impact downstream pharmaceutical applications.

Recent scientific literature highlights innovative applications of (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride in medicinal chemistry. Researchers are exploring its incorporation into novel molecular scaffolds that target specific enzyme families or receptor subtypes. The compound's bicyclic amine structure offers unique opportunities for structure-activity relationship studies, particularly in central nervous system drug development.

Storage and handling of (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride require standard laboratory precautions for amine hydrochloride salts. The compound is typically stable under recommended storage conditions, but proper containment and handling procedures should be followed to maintain its quality and prevent degradation. Material safety data sheets provide detailed guidance for safe laboratory practices when working with this chemical.

The intellectual property landscape surrounding (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride reflects its value in pharmaceutical innovation. Several patents describe synthetic methods and applications of this compound and its derivatives, particularly in therapeutic areas where rigid, nitrogen-containing bicyclic structures show promise. This patent activity underscores the compound's potential in drug discovery pipelines.

Looking ahead, (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride is poised to play an increasingly important role in pharmaceutical research. As drug discovery efforts focus more on three-dimensional molecular architectures and stereochemical complexity, compounds with such well-defined azabicyclic frameworks will likely see expanded applications. Ongoing research continues to uncover new synthetic routes and biological applications for this versatile chemical building block.

For researchers and procurement specialists, understanding the properties and applications of (1R,4R)-2-azabicyclo[2.2.1]heptan-5-one hydrochloride (CAS 1228600-28-9) is essential. This compound represents an important example of how structurally defined chiral intermediates can contribute to advances in medicinal chemistry and drug development. Its unique combination of stereochemical control and molecular rigidity makes it a valuable tool in the search for new therapeutic agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)